Final results of a randomized controlled phase III trial comparing docetaxel (D), combined with cisplatin (C), 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC). - Moiseyenko,V.; Ajani,J.A.; Tjulandin,S. (Proc ASCO, 2005)